Email - info@lenusoncology.com
Mesothelioma is a rare and aggressive form of cancer that develops in the mesothelium, a thin membrane that lines several body cavities, including the chest (pleura), abdomen (peritoneum), and heart (pericardium). It is primarily caused by exposure to asbestos, a naturally occurring mineral widely used in industries such as construction, insulation, and shipbuilding.
Causes of Mesothelioma:
Types of Mesothelioma:
There are also three histological subtypes based on the appearance of the tumor cells: epithelioid, sarcomatoid, and biphasic (or mixed). These subtypes describe the cellular characteristics of the tumor and can provide important information regarding prognosis and treatment options. Here’s a closer look at each subtype:
– Epithelioid mesothelioma is the most common and generally more favorable subtype, accounting for approximately 50-70% of mesothelioma cases.
– It is characterized by epithelioid-shaped tumor cells that closely resemble normal cells and maintain some degree of organization.
– Epithelioid mesothelioma tends to grow at a slower rate compared to other subtypes and has a better response to treatment.
– Patients with epithelioid mesothelioma generally have a longer life expectancy and a more favorable prognosis compared to other subtypes.
– Sarcomatoid mesothelioma is the least common subtype, comprising approximately 10-20% of cases.
– It is characterized by spindle-shaped tumor cells that have a more disorganized and aggressive appearance.
– Sarcomatoid mesothelioma tends to grow more quickly, has a higher likelihood of spreading (metastasizing), and is often resistant to treatment.
– Prognosis for sarcomatoid mesothelioma is generally poorer compared to other subtypes.
– Biphasic mesothelioma, also referred to as mixed mesothelioma, is a subtype that contains a combination of both epithelioid and sarcomatoid cells within the tumor.
– The proportion of each cell type can vary, with some cases having a relatively equal mix, while others may have a predominant cell type.
– Prognosis for biphasic mesothelioma depends on the ratio of epithelioid to sarcomatoid cells, with a better prognosis for cases with a higher proportion of epithelioid cells.
– Treatment approaches for biphasic mesothelioma depend on the predominant cell type and may include a combination of surgery, chemotherapy, radiation therapy, and targeted therapies.
It’s important to note that the histological subtype of mesothelioma is determined through a biopsy and examination of the tumor cells under a microscope by a pathologist. The subtype plays a role in guiding treatment decisions and predicting the prognosis of the disease.
It’s important to note that mesothelioma has a long latency period, often taking 20 to 50 years or more to develop after initial asbestos exposure. If you have a history of asbestos exposure or experience any symptoms associated with mesothelioma, it is crucial to seek medical evaluation and inform your healthcare provider about the potential asbestos exposure. Early detection and intervention can improve treatment outcomes for mesothelioma.
The symptoms of mesothelioma can vary depending on the type of mesothelioma and the stage of the disease. It’s important to note that symptoms may not appear until decades after asbestos exposure. Here are some common symptoms associated with mesothelioma:
– Chest pain or discomfort
– Persistent cough
– Shortness of breath or difficulty breathing
– Fatigue or weakness
– Unexplained weight loss
– Pleural effusion (fluid buildup in the chest cavity)
– Hoarseness or difficulty swallowing
– Persistent or recurring respiratory infections
– Abdominal pain or swelling
– Unexplained weight loss
– Changes in bowel habits, such as diarrhea or constipation
– Nausea or vomiting
– Loss of appetite
– Abdominal mass or lumps
– Ascites (fluid buildup in the abdomen)
– Fatigue or weakness
– Chest pain or discomfort
– Irregular heartbeat or palpitations
– Difficulty breathing or shortness of breath
– Fatigue or weakness
– Fluid retention and swelling in the legs or abdomen
– Persistent cough
– Night sweats
– Painless swelling or a lump in the testicles
– Hydrocele (fluid buildup in the scrotum)
– Testicular pain or discomfort
– Changes in testicular size or shape
It’s important to remember that these symptoms can also be caused by other, more common conditions. However, if you have a history of asbestos exposure or suspect you may have been exposed to asbestos and experience any of these symptoms, it’s crucial to consult with a healthcare professional for a thorough evaluation and appropriate testing. Early detection and diagnosis play a significant role in determining treatment options and improving outcomes for mesothelioma patients.
The diagnosis of mesothelioma typically involves several steps and a comprehensive evaluation by healthcare professionals. Due to the rarity and complexity of the disease, a multidisciplinary approach involving specialists in oncology, pathology, radiology, and surgery is often necessary. Here’s an overview of the diagnostic process for mesothelioma:
– A detailed medical history is taken, with a focus on any known asbestos exposure and symptoms.
– A thorough physical examination is performed, including examination of the affected area and assessment of general health.
– Chest X-ray: This may be the initial imaging test performed to evaluate the chest for abnormalities such as pleural effusion or thickening.
– Computed Tomography (CT) Scan: CT scans provide detailed cross-sectional images of the chest, abdomen, or other areas of concern. They can help visualize tumor size, location, and spread.
– Magnetic Resonance Imaging (MRI) Scan: MRI scans may be used to further evaluate the extent of the tumor and its involvement with nearby structures.
– A biopsy is essential for confirming the diagnosis of mesothelioma. It involves the removal of a small tissue sample for laboratory analysis.
– Different types of biopsies can be performed, including image-guided needle biopsy, thoracoscopy (for pleural mesothelioma), laparoscopy (for peritoneal mesothelioma), or video-assisted thoracic surgery (VATS).
– The biopsy sample is sent to a pathologist who examines the tissue under a microscope to determine if it is consistent with mesothelioma. The pathologist may also perform additional tests to determine the histological subtype of the tumor.
– Molecular and genetic testing of the biopsy sample may be conducted to identify specific genetic alterations or biomarkers that can guide treatment decisions and prognosis.
– Staging is performed to determine the extent and spread of the disease. It helps guide treatment decisions and predict prognosis.
– Staging may involve additional imaging tests, such as positron emission tomography (PET) scans, to assess whether the cancer has spread to other parts of the body.
It’s important to note that diagnosing mesothelioma can be challenging due to its resemblance to other diseases and the need for specialized expertise. Obtaining a definitive diagnosis often requires the involvement of experienced healthcare professionals. If mesothelioma is suspected, seeking consultation from a mesothelioma specialist or a dedicated mesothelioma center is recommended for accurate diagnosis and appropriate treatment planning.
The treatment of mesothelioma depends on several factors, including the stage of the cancer, the location of the tumor, the individual’s overall health, and their treatment goals. The primary treatment modalities for mesothelioma include surgery, chemotherapy, radiation therapy, and targeted therapy. Here’s an overview of the treatment options:
– Surgery aims to remove the tumor and, if possible, surrounding tissues to achieve complete resection. The type of surgery depends on the location and stage of the mesothelioma.
– Pleurectomy/Decortication (P/D): This procedure involves the removal of the pleura and the visible tumor but spares the lung. It is often performed for early-stage pleural mesothelioma.
– Extrapleural Pneumonectomy (EPP): This extensive surgery involves removing the affected lung, pleura, portions of the diaphragm, and sometimes nearby tissues. It is typically reserved for select cases of pleural mesothelioma.
– Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): This procedure is used for peritoneal mesothelioma and involves removing visible tumors from the abdominal cavity and delivering heated chemotherapy directly into the abdomen.
– Chemotherapy involves the use of drugs to kill cancer cells throughout the body. It is often used as the primary systemic treatment for mesothelioma.
– Combination chemotherapy, typically involving platinum-based agents such as cisplatin or carboplatin along with other drugs, is commonly used.
– Neoadjuvant chemotherapy (given before surgery) or adjuvant chemotherapy (given after surgery) may be utilized to improve outcomes.
– Radiation therapy uses high-energy X-rays or other forms of radiation to target and kill cancer cells.
– It may be used before surgery (neoadjuvant radiation therapy) to shrink tumors, or after surgery (adjuvant radiation therapy) to kill remaining cancer cells and prevent local recurrence.
– Palliative radiation therapy may be employed to relieve symptoms and improve quality of life in advanced cases.
– Targeted therapy involves drugs that specifically target specific genetic mutations or molecular abnormalities found in mesothelioma cells.
– For example, drugs targeting the vascular endothelial growth factor (VEGF) pathway, such as bevacizumab, may be used to inhibit tumor blood vessel growth.
– Immunotherapy harnesses the body’s immune system to recognize and attack cancer cells.
– Immune checkpoint inhibitors, such as pembrolizumab and nivolumab, have shown promise in certain cases of mesothelioma.
– Participation in clinical trials may be an option for some individuals. Clinical trials investigate novel treatments, combination therapies, or new approaches to improve outcomes in mesothelioma.
Treatment plans are individualized, and a multidisciplinary team of specialists, including oncologists, surgeons, radiation oncologists, and supportive care providers, collaborate to determine the most appropriate treatment approach for each patient. Palliative care is an essential component to manage symptoms, improve quality of life, and provide supportive care throughout the treatment journey.